TALPHERA, INC. Current Liabilities
TALPHERA, INC. (TLPH) had Current Liabilities of $4.19 million as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LiabilitiesCurrent · last filed 2026-08-12
- 2026-06-30: Liabilities, Current $4.19M.
- 2026-03-31: Liabilities, Current $4.03M.
- 2025-12-31: Liabilities, Current $3.81M.
- 2025-09-30: Liabilities, Current $3.21M.
| Period end | Liabilities, Current |
|---|---|
| 2026-06-30 | $4.19M 10-Q · filed 2026-08-12 |
| 2026-03-31 | $4.03M 10-Q · filed 2026-05-13 |
| 2025-12-31 | $3.81M 10-Q · filed 2026-08-12 |
| 2025-09-30 | $3.21M 10-Q · filed 2025-11-12 |
| 2025-06-30 | $2.63M 10-Q · filed 2025-08-14 |
| 2025-03-31 | $1.99M 10-Q · filed 2025-05-14 |
| 2024-12-31 | $2.65M 10-K · filed 2026-03-23 |
| 2024-09-30 | $2.76M 10-Q · filed 2024-11-13 |
| 2024-06-30 | $3.27M 10-Q · filed 2024-08-14 |
| 2024-03-31 | $3.34M 10-Q · filed 2024-05-14 |
| 2023-12-31 | $4.51M 10-K · filed 2025-03-31 |
| 2023-09-30 | $3.57M 10-Q · filed 2023-11-14 |
| 2023-06-30 | $4.22M 10-Q · filed 2023-08-10 |
| 2023-03-31 | $9.46M 10-Q · filed 2023-05-10 |
| 2022-12-31 | $13.77M 10-K · filed 2024-03-06 |
| 2022-09-30 | $15.65M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $17.69M 10-Q · filed 2022-08-11 |
| 2022-03-31 | $17.03M 10-Q · filed 2022-05-16 |
| 2021-12-31 | $18.51M 8-K · filed 2023-08-01 |
| 2021-09-30 | $17.07M 10-Q · filed 2021-11-15 |
| 2021-06-30 | $15.19M 10-Q · filed 2021-08-16 |
| 2021-03-31 | $15.54M 10-Q · filed 2021-05-17 |
| 2020-12-31 | $17.64M 10-K · filed 2022-03-10 |
| 2020-09-30 | $16.56M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $16.43M 10-Q · filed 2020-08-10 |
| 2020-03-31 | $15.72M 10-Q · filed 2020-05-11 |
| 2019-12-31 | $13.61M 10-K · filed 2021-03-15 |
| 2019-09-30 | $11.43M 10-Q · filed 2019-11-07 |
| 2019-06-30 | $8.29M 10-Q · filed 2019-08-06 |
| 2019-03-31 | $18.95M 10-Q · filed 2019-05-09 |
| 2018-12-31 | $15.93M 10-K · filed 2020-03-16 |
| 2018-09-30 | $14.47M 10-Q · filed 2018-11-05 |
| 2018-06-30 | $13.21M 10-Q · filed 2018-08-02 |
| 2018-03-31 | $13.25M 10-Q · filed 2018-05-10 |
| 2017-12-31 | $13.66M 10-K · filed 2019-03-07 |
| 2017-09-30 | $14.87M 10-Q · filed 2017-11-09 |
| 2017-06-30 | $13.56M 10-Q · filed 2017-08-02 |
| 2017-03-31 | $12.75M 10-Q · filed 2017-05-08 |
| 2016-12-31 | $10.19M 10-K · filed 2018-03-09 |
| 2016-09-30 | $15.53M 10-Q · filed 2016-11-02 |
| 2016-06-30 | $21.03M 10-Q · filed 2016-07-29 |
| 2016-03-31 | $16.80M 10-Q · filed 2016-05-02 |
| 2015-12-31 | $12.78M 10-K · filed 2017-03-03 |
| 2015-09-30 | $7.88M 10-Q · filed 2015-11-03 |
| 2015-06-30 | $13.31M 10-Q · filed 2015-08-04 |
| 2015-03-31 | $15.36M 10-Q · filed 2015-05-05 |
| 2014-12-31 | $13.73M 10-K · filed 2016-03-07 |
| 2014-09-30 | $10.37M 10-Q · filed 2014-11-10 |
| 2014-06-30 | $8.74M 10-Q · filed 2014-08-11 |
| 2014-03-31 | $4.61M 10-Q · filed 2014-05-08 |
| 2013-12-31 | $6.87M 10-K · filed 2015-03-13 |
| 2013-09-30 | $12.43M 10-Q · filed 2013-11-05 |
| 2013-06-30 | $12.12M 10-Q · filed 2013-08-12 |
| 2013-03-31 | $14.98M 10-Q · filed 2013-05-08 |
| 2012-12-31 | $14.33M 10-K · filed 2014-03-17 |
| 2012-09-30 | $12.23M 10-Q · filed 2012-11-06 |
| 2012-06-30 | $10.69M 10-Q · filed 2012-08-10 |
| 2012-03-31 | $8.95M 10-Q · filed 2012-05-09 |
| 2011-12-31 | $7.84M 10-K · filed 2013-03-12 |
| 2011-09-30 | $5.09M 10-Q · filed 2011-11-08 |
| 2011-06-30 | $3.78M 10-Q · filed 2011-08-11 |
| 2010-12-31 | $13.41M 10-K · filed 2012-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |